IVF showdown: which drug combo gives more usable embryos?
NCT ID NCT07457684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 846 women doing their first IVF cycle to compare two drug mixes: follitropin delta plus menotropin versus follitropin alfa plus menotropin. The goal was to see which combination leads to more usable embryos and lower costs. Results help doctors choose the most effective and affordable treatment for their patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IVF OUTCOMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinique ovo
Montreal, Quebec, H4P 2S4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could body fat, not BMI, be the key to IVF success?
- A hormone head start: could estrogen before IVF boost pregnancy chances in PCOS?
- Measuring follicle volume could improve IVF timing for poor responders
- FSH blood tests during IVF could personalize doses
- AI vs. doctors: who picks the best day for IVF?
- AI could predict which sperm will lead to a baby